[CLDX] QoQ Quarter Result on 30-Sep-2009 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 17.59%
YoY- 6.30%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 2,951 3,713 4,733 4,030 2,685 3,732 2,988 -0.82%
PBT -9,191 -6,245 -13,020 -7,174 -8,705 -7,704 -6,386 27.55%
Tax -190 -6,324 -159 36 -36 -165 -1,444 -74.22%
NP -9,525 -6,582 -12,943 -7,174 -8,705 -7,704 -7,453 17.81%
Tax Rate - - - - - - - -
Total Cost 12,476 10,295 17,676 11,204 11,390 11,436 10,442 12.63%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin -322.77 -177.27 -273.46 -178.01 -324.21 -206.45 -249.41 18.81%
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
EPS -4.49 -3.11 -6.13 -6.78 -8.25 -7.30 -7.08 -26.24%
EPS Diluted -4.49 -3.11 -6.13 -6.78 -8.25 -7.30 -7.07 -26.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.